-
公开(公告)号:US20100196472A1
公开(公告)日:2010-08-05
申请号:US12755847
申请日:2010-04-07
IPC分类号: A61K31/165 , A61K9/14 , A61K31/56 , A61K9/28 , A61P29/00 , A61P25/24 , A61P25/06 , A61P25/08 , A61P25/22 , A61P25/18 , A61P11/08 , A61P11/06 , A61P9/00 , A61P1/00 , A61P21/02
CPC分类号: A61K9/2054 , A61K9/2846 , A61K31/165
摘要: A milnacipran formulation that provides delayed and extended release of milnacipran has been developed. The formulation comprises milnacipran or a salt thereof; an extended release excipient, and a delayed release excipient. The formulation provides, upon administration to a human subject, a Tmax of 4-10 hours.
摘要翻译: 已经开发了提供延缓和延长释放米那普仑的米那普仑制剂。 制剂包含米那普仑或其盐; 延长释放赋形剂和延迟释放赋形剂。 在给予受试者时,该制剂提供4-10小时的T max。
-
公开(公告)号:US08021687B2
公开(公告)日:2011-09-20
申请号:US12755847
申请日:2010-04-07
IPC分类号: A61K9/14 , A61K31/56 , A61K9/28 , A61P29/00 , A61P25/24 , A61P25/06 , A61P25/08 , A61P25/22 , A61P25/18 , A61P11/08 , A61P11/06 , A61P9/00 , A61P1/00 , A61P21/02
CPC分类号: A61K9/2054 , A61K9/2846 , A61K31/165
摘要: A milnacipran formulation that provides delayed and extended release of milnacipran has been developed. The formulation comprises milnacipran or a salt thereof; an extended release excipient, and a delayed release excipient. The formulation provides, upon administration to a human subject, a Tmax of 4-10 hours.
摘要翻译: 已经开发了提供延缓和延长释放米那普仑的米那普仑制剂。 制剂包含米那普仑或其盐; 延长释放赋形剂和延迟释放赋形剂。 在给予受试者时,该制剂提供4-10小时的T max。
-
公开(公告)号:US07704527B2
公开(公告)日:2010-04-27
申请号:US12211780
申请日:2008-09-16
CPC分类号: A61K9/2054 , A61K9/2846 , A61K31/165
摘要: A milnacipran formulation that provides delayed and extended release of milnacipran has been developed. The formulation comprises milnacipran or a salt thereof; an extended release excipient, and a delayed release excipient. The formulation provides, upon administration to a human subject, a Tmax of 4-10 hours.
摘要翻译: 已经开发了提供延缓和延长释放米那普仑的米那普仑制剂。 制剂包含米那普仑或其盐; 延长释放赋形剂和延迟释放赋形剂。 在给予受试者时,该制剂提供4-10小时的T max。
-
-